Generative AI imagines new protein structures
MIT researchers develop “FrameDiff,” a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.
MIT researchers develop “FrameDiff,” a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.
BioAutoMATED, an open-source, automated machine-learning platform, aims to help democratize artificial intelligence for research labs.
The inaugural SERC Symposium convened experts from multiple disciplines to explore the challenges and opportunities that arise with the broad applicability of computing in many aspects of society.
Matt Shoulders will lead an interdisciplinary team to improve RuBisCO — the photosynthesis enzyme thought to be the holy grail for improving agricultural yield.
The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.